Presented as poster at the European Society for Coloproctology, September 24–26 2014, Barcelona, Spain
Functional constipation in children and adolescents is a common and invalidating condition. In a minority of patients, symptoms persist despite optimal conservative therapy. The aim of this study was to evaluate whether the short-term effects of sacral neuromodulation (SNM) in children and adolescents with constipation are sustained over prolonged period of time.
Patients aged 10–20 years, with refractory constipation, fulfilling the Rome III criteria, were included in our study. If SNM test treatment showed >50 % improvement in defecation frequency, a permanent stimulator was implanted. Primary outcome measure was defecation frequency during 3 weeks. Secondary endpoints were abdominal pain and Wexner score. To assess sustainability of treatment effect, a survival analysis was performed. Cross-sectional quality of life was assessed using the EQ-5D VAS score.
Thirty girls, mean age 16 (range 10–20), were included. The mean defecation frequency increased from 5.9 (SD 6.5) in 21 days at baseline to 17.4 (SD 11.6) after 3 weeks of test treatment (p < 0.001). During test treatment, abdominal pain and Wexner score decreased from 3.6 to 1.5 and 18.6 to 8.5 (p < 0.001), respectively. Improvement of symptoms sustained during a median follow-up of 22.1 months (12.2–36.8) in 42.9 % of patients. On a scale from 0 to 100, quality of life was 7 points lower than the norm score (mean 70 vs. 77).
SNM is a therapeutic option for children with chronic constipation not responding to intensive oral and/or laxative therapy, providing benefits that appear to be sustained over prolonged period of time.
Tabbers MM, Dilorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, Staiano A, Vandenplas Y, Benninga MA (2014) Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 58(2):265–281. doi: 10.1097/MPG.0000000000000266CrossRef
Bove A, Bellini M, Battaglia E, Bocchini R, Gambaccini D, Bove V, Pucciani F, Altomare DF, Dodi G, Sciaudone G, Falletto E, Piloni V (2012) Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). World J Gastroenterol 18(36):4994–5013. doi: 10.3748/wjg.v18.i36.4994CrossRefPubMedPubMedCentral
Tanagho EA, Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140(6):1331–1339 PubMed
Stolk E, Krabbe P, Busschbach J (2009) Using the internet to collect EQ-5D norm scores: a valid alternative? 24th Scientific Plenary Meeting of the EuroQol Group - Proceedings: 153–165
Knowles CH, Thin N, Gill K, Bhan C, Grimmer K, Lunniss PJ, Williams NS, Scott SM (2012) Prospective randomized double-blind study of temporary sacral nerve stimulation in patients with rectal evacuatory dysfunction and rectal hyposensitivity. Ann Surg 255(4):643–649. doi: 10.1097/SLA.0b013e318247d49fCrossRefPubMed
Clarke MC, Chase JW, Gibb S, Robertson VJ, Catto-Smith A, Hutson JM, Southwell BR (2009) Decreased colonic transit time after transcutaneous interferential electrical stimulation in children with slow transit constipation. J Pediatr Surg 44(2):408–412. doi: 10.1016/j.jpedsurg.2008.10.100CrossRefPubMed
Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd (1992) Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 136(2):165–177 PubMed
- Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment
Aart A. van der Wilt
Bart P. W. van Wunnik
Ingrid J. Han-Geurts
Marc A. Benninga
Cor G. M. I. Baeten
Stephanie O. Breukink
- Springer Berlin Heidelberg
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II